- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 22, 2025 | 37.63M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $369M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $369M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $133M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $133M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.47B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.93B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.65B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.09B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.14B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.6B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 38M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $23M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $21M |
| Capex | Q1 2025 · Mar 31, 2024 | $5M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $31M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $667M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $693M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $140M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $94M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $2.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $2.11 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $57M |
| Net Income | Q1 2025 · Mar 31, 2024 | $79M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $108M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $345M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.8B |